ApoXcel AB is a Swedish AB based in Kumla, operating in the Retail sale of pharmaceutical products sector. Incorporated in 2021, the company has 2 employees and reported revenue of SEK 22.4m in its latest annual filing.
Bolaget har till föremål för sin verksamhet att bedriva handel med receptbelagda apoteksvaror, receptfria apoteksvaror och handelsvaror som lämpar sig för försäljning och distribution till konsumenter genom apotek samt därmed förenlig verksamhet.
In its most recent annual report (2025), ApoXcel AB reported revenue of SEK 22.4m, an increase of 10% on the year before. The figures on this page draw on 4 annual filings covering 2022 to 2025. The bottom line showed a net profit of SEK 15.0k, and the EBITDA margin stood at 1.8%.
At the end of 2025, equity financed 14.7% of the balance sheet, and current assets covered short-term debt 1.1 times.
Frequently asked questions
What is the Org number of ApoXcel AB?
ApoXcel AB is registered with Bolagsverket / SCB under Org 5593341497.
What is the revenue of ApoXcel AB?
ApoXcel AB reported revenue of SEK 22.4m in 2025.
How many employees does ApoXcel AB have?
ApoXcel AB employs 2 people as of the latest annual report.
Who is the CEO of ApoXcel AB?
Humayun Iqbal is the CEO of ApoXcel AB, in role since 2022.
Where is ApoXcel AB headquartered?
ApoXcel AB's registered address is Kvarngatan 23 Lgh 1104.
